欧洲TC249的7个P成员国传统医药立法现状

中医药已在世界范围内迅速发展,但中医药国际标准体系尚未建立,影响了中医药进一步良性发展。制定中医药国际标准战略必须掌握国际标准化组织(ISO)各成员国目前与中医药发展密切相关的技术法规立法现状。笔者通过对ISO中医药技术委员会(ISO/TC249)欧洲地区的7个P成员国(Participating countries)国际传统/替代医药(TM/CAM)立法现状的调查发现,包括中医药在内的植物药在各个成员国拥有很大的市场,部分国家的发展环境良好。《欧盟传统植物药指令2004/24/EC》颁布后,欧洲各成员国对植物药产品的注册和管理都比较严格。TM/CAM的从业者数量相对较少,且缺乏对从业人员的高等教育以及规范管理。

Traditional Medicines Legislation Status of 7 European Participating Countries TC249

Chinese medicine has developed rapidly in the world, but the lnternatlonal standard system has not been established, further affecting the healthy development of Chinese medicine. Technical status of the member states are closely related to the current legislation and regulations in the development of Chinese medicine, which is important for developing international standards for TCM strategies. By the findings of ISO Technical Committee of Traditional Chinese Medicine （ISO/TC249） 7 European P member （Participating countries） International Traditional/Alternative Medicine （TM/CAM） legislative status, herbal medicine in each member country has a large market, a good environment for the development of some countries. After ＂The EU Traditional Herbal Medicinal Products Directive 2004/24/EC ＂ issued by the member states for the registration and management in European, regulation of herbal products become more stringent. There are relatively small quantity of TM/CAM practitioners, lack of education for practitioners and standardized management.